Coherus Oncology Inc (CHRS)

Working Capital Ratio

30.48%

Quarterly · Period ending:

CHRS logo

CHRS Working Capital Ratio

Latest reported30.48%
CHRS Quarterly Working Capital Ratio (-16.91% → 30.48%)
High-resolution chart · PNG

CHRS working capital ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Working Capital Ratio — Quarterly
Period endingWorking Capital Ratio
30.4828%
27.7056%
25.0945%
16.876%
26.1878%
14.858%
13.0653%
14.5461%
14.0661%
11.6789%
22.8493%
35.0654%
46.0068%
47.8396%
50.4402%
50.2727%
56.0491%
60.4487%
64.3271%
47.55%
50.4313%
51.8763%
73.8819%
73.8414%
72.1767%
59.1959%
55.7655%
62.3615%
62.7454%
63.2679%
39.3045%
74.7741%
79.9642%
65.8693%
60.5838%
73.8704%
68.1535%
70.755%
38.4184%
61.8293%
51.1945%
52.451%
24.5819%
35.1793%
54.5555%
60.0602%
52.6698%
54.8048%
57.4098%
-16.7571%
-16.9115%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.